Skip to content

A Clinical Study to evaluate the effect of Mashabaladi Kwatha(Medicated Decoction) Nasapana(Nasapanal Administration)Followed By Prasaranyadi Kashaya (Medicated Decoction)In The Management Of Viswachi Vis-A-Vis Cervical Spondylosis

A Clinical Study to Evaluate The Effect Of Mashabaladi Kwatha Nasapana Followed By Prasaranyadi Kashaya In The Management Of Viswachi Vis-A-Vis Cervical Spondylosis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036122
Enrollment
30
Registered
2021-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Sponsors

DR MONISHA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either Gender Age group between 30- 70years Lakshanas of Vishwachi Signs and Symptoms of Cervical Spondylosis Post covid and Non Covid patients

Exclusion criteria

Exclusion criteria: Subjects with systemic diseases that may interfere with the course of treatment Congenital and Neoplastic conditions of spine Fracture or dislocation of Cervical region

Design outcomes

Primary

MeasureTime frame
Effectiveness of Mashabaladi kwatha nasapana f/b by prasaranyadi kashaya in the management of viswachi vis a vis Cervical SpondylosisTimepoint: one half year

Secondary

MeasureTime frame
NIlTimepoint: Not applicable

Countries

India

Contacts

Public ContactDR ABDUL KHADER

Sri Kalabyraveswara Swamy Ayurvedic Medical college Hospital and Research Centre Banglore

Abukaya2003@gmail.com9845199790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026